SATIRE: An expert witness accused RPM of using the same marketing tactics as Big Solvent companies during the middle school glue-sniffing epidemic of the 1990’s.
The first film in the Stanford Summer Human Rights Series, “Stink!”, was screened on campus on July 19. The series is part of the Camera as a Witness (CAW) Program, which was founded by Stanford teacher and lecturer Jasmina Bojic eight years ago. The three films that will be shown in the Summer Series are selected from the United Nations Association Film Festival (UNAFF) archives, according to Bojic.
Even in his own day, President Theodore Roosevelt was a cultural icon. Buffalo Bill included a segment about Roosevelt’s Rough Riders in his Wild West show. He rendered the 25th president the bastion of masculine bravado. Toymaker Morris Michtom focused on another aspect of Roosevelt’s character — in 1902, Michtom heard how Roosevelt spared a bear’s…
“Why is that man dressed like an astronaut, Dad?” I must have been 10 or so when I asked that question from the back seat of the car while my parents drove by a golf course. The seeming astronaut was a groundskeeper, dressed from head to toe in a white hazmat suit, waving a metal…
No financial compensation is enough to make up for the potential long-term health consequences of egg donation, argued Judy Norsigian, executive director of Our Bodies Ourselves, a nonprofit organization dedicated to women’s health education, at a Tuesday event exploring the controversial topic.
No Stanford-bound medicine was included in the about 1 million packs of birth control pills voluntarily recalled by drug manufacturer Pfizer on Jan. 31 due to incorrect packaging, said a Stanford health administrator. While Vaden Health Center at Stanford does not carry any of the affected medication, campus Peer Health Educators (PHE) have been briefed on how to handle the recall, wrote Robyn Tepper, director of medical services at Vaden, in an email to The Daily.
On Jan. 12, the Stanford biodesign program and the Stanford School of Medicine signed a memorandum of understanding (MOU) with the Food and Drug Administration (FDA). This memorandum gives both organizations a foundation that allows future collaboration on projects, such as working to improve the regulatory process for innovations in medical technology.
Investigators at the School of Medicine have shown that engineered nanoparticles can be safely administered in a mouse study. Their finding, published April 20 in Science Translational Magazine, could bring about human trials that utilize the nanoparticles in the detection of colorectal and other cancers.